Genomic editing with CRISPR/Cas9 for production of hereditary persistance of fetal...
New therapeutic strategies for sickle cell disease using CRISPR/Cas9 to produce he...
Pathophysiological mechanisms and treatment of red blood cell abnormalities
Multi-user equipment approved in grant 19/18886-1: PeriCam PSI NR
New therapeutic strategies for sickle-cell disease using CRISPR/Cas9 to produce he...
Hereditary hemoglobin disorders: molecular genetics, clinical features and animal ...
Fetal hemoglobin induction as a treatment strategy for sickle cell anemia using ge...